Evidence map›Paper›PMID 25833879›Full record

ArticleEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2015

Optimizing stroke prevention in atrial fibrillation: better adherence and compliance from patients and physicians leads to better outcomes.

Tatjana S Potpara, Deirdre A Lane, Gregory Y H Lip

Registry-linked trialAbstract readEditorialComment
PubMed Publisher
In one paragraph

Article in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04857268 (Diagnostic Validation of Wearable Continuous ECG Monitoring Patch, ATP-C120, in High Risk Patients for New-onset Atrial Fibrillation), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04857268 naunknown statusnot on this mapstarted 2020, after this paper: background citation

Diagnostic Validation of Wearable Continuous ECG Monitoring Patch, ATP-C120, in High Risk Patients for New-onset Atrial Fibrillation

TypeinterventionalSponsorSeoul National University Bundang HospitalRan2020 to 2023Enrolled320ConditionsAtrial Fibrillation New OnsetArmswearable continuous ECG monitoring patch, ATP-C120
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Tatjana S PotparaSchool of Medicine, Belgrade University, Belgrade, Serbia Cardiology Clinic, Clinical Centre of Serbia, Visegradska 26, Belgrade 11000, Serbia tanjapotpara@gmail.com tatjana.potpara@mfub.bg.ac.rs.
Deirdre A LaneUniversity of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham B18 7QH, UK.
Gregory Y H LipSchool of Medicine, Belgrade University, Belgrade, Serbia University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham B18 7QH, UK Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Faculty of Health, Aalborg University, Aalborg, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug Administration ScheduleMedication AdherenceRegistriesAnticoagulantsAtrial FibrillationFemaleHumansMaleRivaroxabanStrokeThromboembolismWithholding TreatmentAnticoagulantsRivaroxaban

Identifiers

PMID25833879

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.